BRPI0016638B8 - compostos análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos, processo para preparar os mesmos, composição farmacêutica e processo para prepará-la. - Google Patents
compostos análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos, processo para preparar os mesmos, composição farmacêutica e processo para prepará-la.Info
- Publication number
- BRPI0016638B8 BRPI0016638B8 BRPI0016638A BR0016638A BRPI0016638B8 BR PI0016638 B8 BRPI0016638 B8 BR PI0016638B8 BR PI0016638 A BRPI0016638 A BR PI0016638A BR 0016638 A BR0016638 A BR 0016638A BR PI0016638 B8 BRPI0016638 B8 BR PI0016638B8
- Authority
- BR
- Brazil
- Prior art keywords
- aryl
- alkyl
- substituted
- preparing
- optionally substituted
- Prior art date
Links
- 239000002249 anxiolytic agent Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 homopiperidinyl Chemical group 0.000 abstract 5
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 230000001771 impaired effect Effects 0.000 abstract 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 2
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical class 0.000 abstract 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
"análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos". a presente invenção refere-se a compostos com atividade de relaxamento fúndico de fórmula (i) suas pró-drogas, n-óxidos, sais de adição, aminas quaternárias e formas estereoquimicamente isoméricas em que o radical bivalente representa uma homopiperidinila saturada ou não-saturada tendo uma ligação dupla, e em que o referido radical bivalente é substituído com r^ 2^ sendo hidrogênio, hidróxi, c~ 1-4~alquila, ou c~ 1-4~alquilóxi; -a^ 1^=a^ 2^-a^ 3^=a^ 4^ representa um radical bivalente opcionalmente substituído; r^ 1^ é hidrogênio, c~ 1-6~alquila, arila^ 1^, c~ 1-6~alquila substituída com arila^ 1^, c~ 1-4~ alquiloxicarbonila, aril^ 1^carbonila, aril^ 1^c~ 1-6~alquilcarbonila, c~ 1-4~ alquilcarbonila, trifluorometila, trifluorometilcarbonila, c~ 1-6~alquilsulfonila, aril^ 1^sulfonila, metanossulfonila, benzenossulfonila, trifluorometanossulfonila ou dimetilsulfamoíla; x representa o, s ou nr^ 3^ em que r^ 3^ é hidrogênio, c~ 1-6~alquila, metanossulfonila, benzenossulfonila, trifluorometanossulfonila, dimetilsulfamoíla, c~ 1-4~alquila substituída com arila^ 2^ e opcionalmente com hidróxi, c~ 1-4~alquilcarbonilc~ 1-4~ alquila substituída com arila^ 2^; arila^ 1^ é fenila opcionalmente substituída, piridinila opcionalmente substituída, naftila, quinolinila ou 1,3-benzodioxolila; arila^ 2^ é fenila opcionalmente substituída. processos para preparação dos referidos produtos, formulações compreendendo os referidos produtos e seu uso como medicamento são descritos, em particular para tratamento de sintomas dispépticos, síndrome de intestino irritável e outras condições relacionadas com relaxamento dificultado ou deficiente do fundo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99204441 | 1999-12-21 | ||
| PCT/EP2000/012858 WO2001046189A1 (en) | 1999-12-21 | 2000-12-14 | Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0016638A BR0016638A (pt) | 2002-10-01 |
| BR0016638B1 BR0016638B1 (pt) | 2013-02-05 |
| BRPI0016638B8 true BRPI0016638B8 (pt) | 2017-04-25 |
Family
ID=8241040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0016638A BRPI0016638B8 (pt) | 1999-12-21 | 2000-12-14 | compostos análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos, processo para preparar os mesmos, composição farmacêutica e processo para prepará-la. |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7304052B2 (pt) |
| EP (1) | EP1250337B1 (pt) |
| JP (1) | JP4852210B2 (pt) |
| KR (1) | KR100715351B1 (pt) |
| CN (1) | CN100343251C (pt) |
| AT (1) | ATE416174T1 (pt) |
| AU (1) | AU781144B2 (pt) |
| BG (1) | BG65784B1 (pt) |
| BR (1) | BRPI0016638B8 (pt) |
| CA (1) | CA2393158C (pt) |
| CY (1) | CY1108844T1 (pt) |
| CZ (1) | CZ299803B6 (pt) |
| DE (1) | DE60041001D1 (pt) |
| DK (1) | DK1250337T3 (pt) |
| EA (1) | EA005851B1 (pt) |
| EE (1) | EE05182B1 (pt) |
| ES (1) | ES2317856T3 (pt) |
| HK (1) | HK1053109B (pt) |
| HR (1) | HRP20020518B1 (pt) |
| HU (1) | HU229929B1 (pt) |
| IL (2) | IL150310A0 (pt) |
| MX (1) | MXPA02006346A (pt) |
| MY (1) | MY127758A (pt) |
| NO (1) | NO322362B1 (pt) |
| NZ (1) | NZ518816A (pt) |
| PL (1) | PL199678B1 (pt) |
| PT (1) | PT1250337E (pt) |
| SI (1) | SI1250337T1 (pt) |
| SK (1) | SK287113B6 (pt) |
| TW (1) | TWI225488B (pt) |
| UA (1) | UA73963C2 (pt) |
| WO (1) | WO2001046189A1 (pt) |
| ZA (1) | ZA200204983B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI225488B (en) | 1999-12-21 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivatives of homopiperidinyl substituted benzimidazole analogues |
| JO2352B1 (en) * | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Compounds for the treatment of non-adaptation of the bottom of the uterus |
| CA2473236A1 (en) | 2002-01-10 | 2003-07-24 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| EP1719765A4 (en) * | 2004-02-19 | 2009-01-07 | Banyu Pharma Co Ltd | NEW SULFONAMIDE DERIVATIVE |
| CA2671857C (en) * | 2007-01-25 | 2013-11-19 | Janssen Pharmaceutica Nv | 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| EA201591390A1 (ru) | 2010-06-24 | 2016-06-30 | Джилид Сайэнс, Инк. | Пиразол[1,5-a]пиримидины для противовирусного лечения |
| EP2643304A2 (en) * | 2010-11-24 | 2013-10-02 | Sequent Scientific Ltd. | A process for preparation of albendazole |
| JP2014159375A (ja) * | 2011-06-15 | 2014-09-04 | Takeda Chem Ind Ltd | アゼパン化合物 |
| EP2794611B1 (en) | 2011-12-22 | 2017-10-11 | Gilead Sciences, Inc. | Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| CN106986869A (zh) | 2012-04-17 | 2017-07-28 | 吉利德科学公司 | 用于抗病毒治疗的化合物和方法 |
| WO2015091584A1 (en) * | 2013-12-18 | 2015-06-25 | F. Hoffmann-La Roche Ag | Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2060197C3 (de) | 1970-12-08 | 1979-02-22 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von 2-Aminobenzothiazol und dessen N-Alkylsubstitutionsprodukten |
| US4093726A (en) | 1976-12-02 | 1978-06-06 | Abbott Laboratories | N-(2-benzimidazolyl)-piperazines |
| ES482789A0 (es) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
| JPS5879983A (ja) * | 1981-11-06 | 1983-05-13 | Kanebo Ltd | 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物 |
| FR2528526A1 (fr) * | 1982-06-09 | 1983-12-16 | Sfr Sa Robinetterie | Butee se fixant dans un alesage d'un dispositif |
| DE3224512A1 (de) * | 1982-07-01 | 1984-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| DE3634066A1 (de) * | 1986-10-07 | 1988-04-21 | Boehringer Mannheim Gmbh | Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel |
| JPH0260197A (ja) * | 1988-08-26 | 1990-02-28 | Nec Corp | パッケージ構造 |
| FR2674856B1 (fr) * | 1991-04-05 | 1993-07-30 | Esteve Labor Dr | Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments. |
| IL101851A (en) * | 1991-06-13 | 1996-05-14 | Janssen Pharmaceutica Nv | History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition |
| DE4237656A1 (de) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | Benzimidazolderivate |
| EP0649305A1 (en) * | 1992-07-08 | 1995-04-26 | Monsanto Company | Benzimidazoles for alleviating stomach ulcers in swine |
| ES2048109B1 (es) | 1992-07-20 | 1994-12-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol. |
| EP0711768B1 (en) * | 1994-05-31 | 2002-02-13 | Mitsui Chemicals, Inc. | Benzimidazole derivative |
| FR2766822B1 (fr) * | 1997-07-30 | 2001-02-23 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US6150379A (en) * | 1997-11-26 | 2000-11-21 | Axys Pharmaceuticals, Inc. | Compounds and compositions as anticoagulants |
| TWI225488B (en) | 1999-12-21 | 2004-12-21 | Janssen Pharmaceutica Nv | Derivatives of homopiperidinyl substituted benzimidazole analogues |
-
2000
- 2000-12-11 TW TW089126315A patent/TWI225488B/zh not_active IP Right Cessation
- 2000-12-14 CA CA2393158A patent/CA2393158C/en not_active Expired - Fee Related
- 2000-12-14 PT PT00985180T patent/PT1250337E/pt unknown
- 2000-12-14 DK DK00985180T patent/DK1250337T3/da active
- 2000-12-14 AU AU21673/01A patent/AU781144B2/en not_active Ceased
- 2000-12-14 US US10/169,011 patent/US7304052B2/en not_active Expired - Fee Related
- 2000-12-14 CZ CZ20022055A patent/CZ299803B6/cs not_active IP Right Cessation
- 2000-12-14 BR BRPI0016638A patent/BRPI0016638B8/pt not_active IP Right Cessation
- 2000-12-14 IL IL15031000A patent/IL150310A0/xx unknown
- 2000-12-14 PL PL355442A patent/PL199678B1/pl unknown
- 2000-12-14 SI SI200031019T patent/SI1250337T1/sl unknown
- 2000-12-14 ES ES00985180T patent/ES2317856T3/es not_active Expired - Lifetime
- 2000-12-14 DE DE60041001T patent/DE60041001D1/de not_active Expired - Lifetime
- 2000-12-14 EE EEP200200326A patent/EE05182B1/xx not_active IP Right Cessation
- 2000-12-14 EA EA200200700A patent/EA005851B1/ru not_active IP Right Cessation
- 2000-12-14 MX MXPA02006346A patent/MXPA02006346A/es active IP Right Grant
- 2000-12-14 SK SK854-2002A patent/SK287113B6/sk not_active IP Right Cessation
- 2000-12-14 JP JP2001547099A patent/JP4852210B2/ja not_active Expired - Fee Related
- 2000-12-14 EP EP00985180A patent/EP1250337B1/en not_active Expired - Lifetime
- 2000-12-14 KR KR1020027006004A patent/KR100715351B1/ko not_active IP Right Cessation
- 2000-12-14 NZ NZ518816A patent/NZ518816A/xx not_active IP Right Cessation
- 2000-12-14 HU HU0203847A patent/HU229929B1/hu unknown
- 2000-12-14 UA UA2002065092A patent/UA73963C2/uk unknown
- 2000-12-14 CN CNB008174458A patent/CN100343251C/zh not_active Expired - Fee Related
- 2000-12-14 WO PCT/EP2000/012858 patent/WO2001046189A1/en active IP Right Grant
- 2000-12-14 AT AT00985180T patent/ATE416174T1/de active
- 2000-12-20 MY MYPI20006015A patent/MY127758A/en unknown
-
2002
- 2002-05-29 BG BG106749A patent/BG65784B1/bg unknown
- 2002-06-13 HR HR20020518A patent/HRP20020518B1/xx not_active IP Right Cessation
- 2002-06-19 IL IL150310A patent/IL150310A/en not_active IP Right Cessation
- 2002-06-20 ZA ZA200204983A patent/ZA200204983B/en unknown
- 2002-06-20 NO NO20022977A patent/NO322362B1/no not_active IP Right Cessation
-
2003
- 2003-07-23 HK HK03105325.2A patent/HK1053109B/zh not_active IP Right Cessation
-
2009
- 2009-03-03 CY CY20091100243T patent/CY1108844T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0313160A (pt) | Composto, composição farmacêutica, métodos para tratar uma condição e um neoplasmo suscetìvel em um animal em um animal, processo para preparar um composto e uso de um composto | |
| BR0209271A (pt) | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto | |
| BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
| BRPI0313942B8 (pt) | derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas | |
| AR035666A1 (es) | Imidazo[4,5-c]quinolin-4-aminas y tetrahidroimidazo[4,5-c]quinolin-4-aminas, composiciones farmaceuticas que las comprenden, uso de dichos compuestos en la preparacion de medicamentos, e intermediarios utiles en la sintesis de dichos compuestos | |
| BRPI0016638B8 (pt) | compostos análogos de homopiperidilbenzimidazóis substituídos como relaxantes fúndicos, processo para preparar os mesmos, composição farmacêutica e processo para prepará-la. | |
| MXPA04004601A (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
| BR9610051A (pt) | Uso de um composto, processo de preparação do mesmo, formulação ou composição farmacêutica contendo um composto, composição farmacêutica, e, processo de tratamento terapeutico | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BRPI0412291A (pt) | antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia | |
| BR9707606B1 (pt) | ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem. | |
| IT1288290B1 (it) | Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| DK1697370T3 (da) | Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer | |
| BR0209518A (pt) | Novos derivados arilheteroalquilamina | |
| AR007827A1 (es) | 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos. | |
| BR0012951A (pt) | Agonistas de retinóides seletivos | |
| BR0111126A (pt) | Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos | |
| BR9812088A (pt) | Combinação de componentes, uso desta, processos para a preparação da mesma, para o tratamento de distúrbios afetivos, para o tratamento de depressão, e para melhorar o inìcio de ação terapêutica, formulação farmacêutica, e, kit | |
| AR029190A1 (es) | Composiciones que contienen derivados del acido hidroxieicosatetraenoico y uso para la manufactura de un medicamento en el tratamiento de trastornos del ojo seco | |
| BRPI0407253A (pt) | Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos | |
| TR200400526T4 (tr) | Göz kurumasının tedavisi için lipoksin A4 ve analogları | |
| RU2002117649A (ru) | Фармацевтические композиции, содержащие золмитриптан | |
| BR0012610A (pt) | Novo derivado de difenilpiperidina | |
| BR9916669A (pt) | Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/02/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 19A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2544 DE 08-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |